Current issue
Journal content
Articles in press
Archive
About the Journal
About the Polish Annals of Medicine
Editorial Board
Abstracting & indexing
Open Access policy
Charges
Affiliated institutions
Contact
Instructions
Peer review process
Guide for authors
Publication ethics
Ethics and Patient Consent
User License
Usage of third party materials
Disclaimer
Statement on Artificial Intelligence
Reviewers
Guide for reviewers
Review Form
RESEARCH PAPER
Histopathologic criteria to differentiate autoimmune hepatitis from chronic viral hepatitis (B, C) in liver biopsy
1
Department of Pathology-Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2
Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
3
Department of Pathology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Submission date: 2016-08-02
Acceptance date: 2016-11-21
Online publication date: 2016-12-08
Publication date: 2019-12-20
Corresponding author
Pardis Nematollahi
Department of Pathology, Faculty of Medicine, Isfahan University of Medical Sciences, Hezar Jerib St, Isfahan, Iran. Tel.: +98 9132025410; fax: +98 21 8977 6525.
Department of Pathology, Faculty of Medicine, Isfahan University of Medical Sciences, Hezar Jerib St, Isfahan, Iran. Tel.: +98 9132025410; fax: +98 21 8977 6525.
Pol. Ann. Med. 2017;24(2):175-179
KEYWORDS
ABSTRACT
Introduction:
Chronic hepatitis is a common disease in the community which is caused mainly by viral agents or immune factors. Differential diagnosis of hepatitis in the treatment is very important due to different therapy.
Aim:
This study is designed to determine importance of histological findings of autoimmune hepatitis (AIH) to distinguish from other chronic hepatitis.
Material and methods:
In a cross-sectional study, 112 patients with hepatitis (autoimmune, B and C) were assessed about histopathological criteria on liver biopsy.
Results:
Among the 12 indicators in histopathologic criteria, 5 indexes of interface hepatitis, lymphoid follicle in port area, emperipolesis, hepatic rosette and ground glass hepatocyte have the ability to differentiate types of hepatitis.
Discussion:
Clinical and laboratory features of hepatitis B and C can overlap with those of AIH. From therapeutic point of view, distinguishing AIH from viral hepatitis is vital, as their treatment is totally different. Some histopathologic criteria on liver biopsy accompanied with other clinical and paraclinical findings help differentiation of them.
Conclusions:
Histopathological parameters can differentiate types of hepatitis at an acceptable level which among them, interface hepatitis is used to differentiate between AIH and hepatitis B, lymphoid follicle in port area is used to differentiate hepatitis C and the other two types, emperipolesis to differentiate AIH from the other two types, hepatic rosette to differentiate AIH from the other two types and ground glass hepatocyte to differentiate hepatitis B from the other two types.
Chronic hepatitis is a common disease in the community which is caused mainly by viral agents or immune factors. Differential diagnosis of hepatitis in the treatment is very important due to different therapy.
Aim:
This study is designed to determine importance of histological findings of autoimmune hepatitis (AIH) to distinguish from other chronic hepatitis.
Material and methods:
In a cross-sectional study, 112 patients with hepatitis (autoimmune, B and C) were assessed about histopathological criteria on liver biopsy.
Results:
Among the 12 indicators in histopathologic criteria, 5 indexes of interface hepatitis, lymphoid follicle in port area, emperipolesis, hepatic rosette and ground glass hepatocyte have the ability to differentiate types of hepatitis.
Discussion:
Clinical and laboratory features of hepatitis B and C can overlap with those of AIH. From therapeutic point of view, distinguishing AIH from viral hepatitis is vital, as their treatment is totally different. Some histopathologic criteria on liver biopsy accompanied with other clinical and paraclinical findings help differentiation of them.
Conclusions:
Histopathological parameters can differentiate types of hepatitis at an acceptable level which among them, interface hepatitis is used to differentiate between AIH and hepatitis B, lymphoid follicle in port area is used to differentiate hepatitis C and the other two types, emperipolesis to differentiate AIH from the other two types, hepatic rosette to differentiate AIH from the other two types and ground glass hepatocyte to differentiate hepatitis B from the other two types.
ACKNOWLEDGEMENTS
Authors thank medical faculty of Isfahan University of Medical Sciences to support this study.
CONFLICT OF INTEREST
None declared.
REFERENCES (20)
1.
Guido M, Mangia A, Faa G. Chronic viral hepatitis: the histology report. Dig Liver Dis. 2011;43(suppl 4):S331–S343.
2.
Firpi RJ, Nelson DR. Viral hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program. 2006;375–380.
3.
Malik TA, Saeed S. Autoimmune hepatitis: a review. J Pak Med Assoc. 2010;60(5):381–387.
4.
Desmet V. Liver lesions in hepatitis B viral infection. Yale J Biol Med. 1988;61(1):61.
6.
Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 1992;15(4):572–577.
8.
Tanikawa K, Kage M, Komuta M, et al. Pathological analysis of oxyphilic granular hepatocytes and hepatocellular mitochondria in chronic hepatitis C. Hepatol Res. 2007;37(6):425–432.
9.
Clément S, Negro F. Hepatitis C virus: the viral way to fatty liver. J Hepatol. 2007;46(6):985–987.
10.
Haque S, Chandra B, Gerber M, Lok ASF. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol. 1996;27(12):1277–1281.
11.
Goldin R, Levine T, Foster G, Thomas HC. Granulomas and hepatitis C. Histopathology. 1996;28(3):265–267.
12.
Gabriel A, Kukla M, Wilk M, Liszka Ł, Petelenz M, Musialik J. Angiogenesis in chronic hepatitis C is associated with inflammatory activity grade and fibrosis stage. Pathol Res Pract. 2009;205(11):758–764.
13.
Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology. 2006;43(2 suppl 1):S132–S144.
14.
Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36(2):479–497.
15.
Hennes EM, Zeniya M, Czaja A, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–176.
17.
Dalekos G, Zachou K, Liaskos C, Gatselis N. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med. 2002;13(5):293–303.
18.
Dalekos GN, Wedemeyer H, Obermayer-Straub P, et al. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during a-interferon treatment. J Hepatol. 1999;30(3):366–375.
19.
Alvarez F, Berg P, Bianchi F, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929–938.
20.
Kumari N, Kathuria R, Srivastav A, Krishnani N, Poddar U, Yachha SK. Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children. Eur J Gastroenterol Hepatol. 2013;25(3):333–337.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
